5 Einträge gefunden

1. RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia

   1. Jerchel, I S
   2. Hoogkamer, A Q
   3. Ariës, I M
   4. Steeghs, E M P
   5. Boer, J M
   6. Besselink, N J M
   7. Boeree, A

   2018 - Forschungsinformationssystem des UKE
2. EMP1, a novel poor prognostic factor in pediatric leukemia regulates prednisolone resistance, cell proliferation, migration and adhesion

   1. Ariës, I M
   2. Jerchel, I S
   3. van den Dungen, R E S R
   4. van den Berk, L C J
   5. Boer, J M
   6. Horstmann, M A
   7. Escherich, G

   2014 - Forschungsinformationssystem des UKE
3. Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia

   1. van der Veer, A
   2. van der Velden, V H J
   3. Willemse, M E
   4. Hoogeveen, P G
   5. Petricoin, E F
   6. Beverloo, H B
   7. Escherich, G

   2014 - Forschungsinformationssystem des UKE
4. Identification of novel NOTCH1 mutations: increasing our knowledge of the NOTCH signaling pathway

   1. Gallo Llorente, Lucía
   2. Luther, H
   3. Schneppenheim, R
   4. Zimmermann, M
   5. Felice, M
   6. Horstmann, M A

   2014 - Forschungsinformationssystem des UKE
5. Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97.

   1. Escherich, G
   2. Horstmann, M A
   3. Zimmermann, M
   4. Janka-Schaub, G E

   2010 - Forschungsinformationssystem des UKE